Mouse Model for Combined Oral Contraceptive Administration in Diet
DOI:
https://doi.org/10.53646/jknm3v08Keywords:
Oral contraceptives, estrous cycle, mouse model, translationalAbstract
BACKGROUND: Combined oral contraceptives (COCs), containing synthetic estrogen and progestin, are widely used for birth control and managing various conditions. A wide variety of COC formulations are prescribed, yet formulation-specific effects on health remain poorly understood. This study investigated the impacts of two COC formulations––low-dose ethinyl estradiol (EE) with high androgenicity progestin, levonorgestrel (LNG) and high-dose EE and low androgenicity progestin, desogestrel (DSG)––on estrous cycling and anthropometrics in a mouse model.
METHODS: Eighteen female C57Bl/6J mice (12 weeks old) were randomized into three groups: low-dose EE + LNG (2mg/kg EE, 200 mg/kg DSG), high-dose EE + DSG (5mg/kg EE, 200 mg/kg DSG) and a control group. Hormones were administered via diet over 8 weeks. Body weight, food intake and estrous cycle stages were monitored, and serum hormone levels were measured at the time of euthanasia.
RESULTS: Both COC formulations disrupted estrous cycling, with the EE + LNG group spending more time in diestrus and the EE + DSG group in metestrus, compared to the controls. No significant differences in body weight change or serum progesterone levels were observed, though serum estradiol levels were lower in both experimental groups compared to the control group.
CONCLUSION: These findings contribute to the refinement of translational rodent models for COC research and provide insight into the differential effect of the composition of different COC’s.
References
1. United Nations Department of Economic and Social Affairs. Contraceptive use by method 2019: Data booklet. 2019. https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_contraceptiveusebymethod_databooklet.pdf
2. Weill A, Dalichampt M, Raguideau F, et al. (2016) Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million french women: Cohort study. BMJ 353:i2002. https://doi.org/10.1136/bmj.i2002
3. Shapiro S, Dinger J (2010) Risk of venous thromboembolism among users of oral contraceptives: A review of two recently published studies. J Fam Plann Reprod Health Care 36(1):33-38. https://doi.org/10.1783/147118910790291037
4. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK (1996) Stroke in users of low-dose oral contraceptives. N Engl J Med 335(1):8-15. https://doi.org/10.1056/nejm199607043350102
5. Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M (2014) Steroidal contraceptives: Effect on bone fractures in women. Cochrane Database Syst Rev 2014(6):Cd006033. https://doi.org/10.1002/14651858.CD006033.pub5
6. Casto KV, Jordan T, Petersen N (2022) Hormone-based models for comparing menstrual cycle and hormonal contraceptive effects on human resting-state functional connectivity. Front Neuroendocrinol 67:101036. https://doi.org/10.1016/j.yfrne.2022.101036
7. Chari T, Griswold S, Andrews NA, Fagiolini M (2020) The stage of the estrus cycle is critical for interpretation of female mouse social interaction behavior. Front Behav Neurosci 14:113. https://doi.org/10.3389/fnbeh.2020.00113
8. de Bastos M, Stegeman BH, Rosendaal FR, et al. (2014) Combined oral contraceptives: Venous thrombosis. Cochrane Database Syst Rev 2014(3):Cd010813. https://doi.org/10.1002/14651858.CD010813.pub2
9. Birtch RL, Olatunbosun OA, Pierson RA (2006) Ovarian follicular dynamics during conventional vs. Continuous oral contraceptive use. Contraception 73(3):235-243. https://doi.org/10.1016/j.contraception.2005.09.009
10. Vessey MP, Doll R (1968) Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J 2(5599):199-205. https://doi.org/10.1136/bmj.2.5599.199
11. Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF (2013) 20 microg versus >20 microg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev (8):Cd003989. https://doi.org/10.1002/14651858.CD003989.pub5
12. Jones EE (1995) Androgenic effects of oral contraceptives: Implications for patient compliance. Am J Med 98(1a):116s-119s. https://doi.org/10.1016/s0002-9343(99)80069-2
13. Leblanc ES, Laws A (1999) Benefits and risks of third-generation oral contraceptives. J Gen Intern Med 14(10):625-632. https://doi.org/10.1046/j.1525-1497.1999.08108.x
14. Dragoman MV, Tepper NK, Fu R, Curtis KM, Chou R, Gaffield ME (2018) A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet 141(3):287-294. https://doi.org/10.1002/ijgo.12455
15. Shultz SJ, Schmitz RJ, Benjaminse A, Collins M, Ford K, Kulas AS (2015) Acl research retreat vii: An update on anterior cruciate ligament injury risk factor identification, screening, and prevention. J Athl Train 50(10):1076-1093. https://doi.org/10.4085/1062-6050-50.10.06
16. DeFroda SF, Bokshan SL, Worobey S, Ready L, Daniels AH, Owens BD (2019) Oral contraceptives provide protection against anterior cruciate ligament tears: A national database study of 165,748 female patients. Phys Sportsmed:1-5. https://doi.org/10.1080/00913847.2019.1600334
17. Herzberg SD, Motu'apuaka ML, Lambert W, Fu R, Brady J, Guise JM (2017) The effect of menstrual cycle and contraceptives on acl injuries and laxity: A systematic review and meta-analysis. Orthop J Sports Med 5(7):2325967117718781. https://doi.org/10.1177/2325967117718781
18. Konopka JA, Hsue LJ, Dragoo JL (2019) Effect of oral contraceptives on soft tissue injury risk, soft tissue laxity, and muscle strength: A systematic review of the literature. Orthop J Sports Med 7(3):2325967119831061. https://doi.org/10.1177/2325967119831061
19. Rodriguez LA, Casey E, Crossley E, Williams N, Dhaher YY (2024) The hormonal profile in women using combined monophasic oral contraceptive pills varies across the pill cycle: A temporal analysis of serum endogenous and exogenous hormones using liquid chromatography with tandem mass spectroscopy. Am J Physiol Endocrinol Metab 327(1):E121-e133. https://doi.org/10.1152/ajpendo.00418.2023
20. Elliott-Sale KJ, Minahan CL, de Jonge X, et al. (2021) Methodological considerations for studies in sport and exercise science with women as participants: A working guide for standards of practice for research on women. Sports Med 51(5):843-861. https://doi.org/10.1007/s40279-021-01435-8
21. Knobil E, Neill JD. The physiology of reproduction. Vol 2. New York: Raven Press; 1994.
22. Lacasse JM, Gomez-Perales E, Brake WG (2022) Modeling hormonal contraception in female rats: A framework for studies in behavioral neurobiology. Front Neuroendocrinol 67:101020. https://doi.org/10.1016/j.yfrne.2022.101020
23. Quignon C (2023) Collection and analysis of vaginal smears to assess reproductive stage in mice. Curr Protoc 3(9):e887. https://doi.org/10.1002/cpz1.887
24. Byers SL, Wiles MV, Dunn SL, Taft RA (2012) Mouse estrous cycle identification tool and images. PLoS One 7(4):e35538. https://doi.org/10.1371/journal.pone.0035538
25. Caligioni CS (2009) Assessing reproductive status/stages in mice. Curr Protoc Neurosci Appendix 4:Appendix 4I. https://doi.org/10.1002/0471142301.nsa04is48
26. Fuller KNZ, McCoin CS, Stierwalt H, et al. (2022) Oral combined contraceptives induce liver mitochondrial reactive oxygen species and whole-body metabolic adaptations in female mice. J Physiol 600(24):5215-5245. https://doi.org/10.1113/jp283733
27. Schuh KM, Ahmed J, Kwak E, et al. (2024) A mouse model of oral contraceptive exposure: Depression, motivation, and the stress response. Horm Behav 158:105470. https://doi.org/10.1016/j.yhbeh.2023.105470
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Journal of Women's Sports Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.